Case Study: Is it a good time to start thinking about investing in China?

The reopening of the Chinese economy after the pandemic could present investment opportunities for those interested in the Chinese market.

MTQ Corporation (SGX:M05) – Promising Business Turnaround Potential with Strong Financial Performance

MTQ Corporation SGX:M05 presents an attractive investment opportunity with its strong financials and potential for business turnaround.

With an attractive valuation, positive financial outlook, and commitment to innovation, Wabash National $WNC is positioned for success.

Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.

I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.

My annual investment review for 2022. This year has been a rollercoaster for the stock market, here are the key takeaways from my portfolio.

We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.

VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.

uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.

Here is my summary and review of "Insider Buy Superstocks". It has some important concepts to achieve great investment returns.